FDA Approves First Myopia-Control Spectacle Lens for Children

According to this report, the FDA has approved the Essilor Stellest lens, the first spectacle lens in the US


designed to slow myopia progression in children. Already used internationally, Stellest lenses use over 1,000 tiny lenslets arranged in concentric rings to create peripheral defocus, interrupting signals that drive eye elongation. A two-year clinical trial showed a 71% reduction in myopia progression and a 53% decrease in axial length growth compared with standard single-vision lenses, with no serious adverse effects. The lens is indicated for children aged 6–12 and must be worn at least 12 hours daily. Availability in the US is expected within weeks.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH